Reardon Andrew - Insider Non-Derivative Transactions at LIGAND PHARMACEUTICALS INC (LGND) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 23, 2024, Reardon Andrew's relationship to LIGAND PHARMACEUTICALS INC (LGND) is Officer (CLO & Secretary), and currently has 24,534 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LGND insiders.
Data Source: SEC.
Reardon Andrew - Insider Non-Derivative Transactions of LGND Common Stock
Reardon Andrew - Insider Non-Derivative Transactions at LGND
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 24, 2024 | Sell -- (Common Stock) | 2000 | 99.6 | 22534 |
| Sep 24, 2024 | M -- (Common Stock) | 2000 | 52.27 | 24534 |
| Aug 29, 2024 | Sell -- (Common Stock) | 1500 | 106.39 | 22534 |
| Aug 29, 2024 | M -- (Common Stock) | 1500 | 52.27 | 24034 |
| Jun 29, 2024 | J -- (Common Stock) | 329 | 60.71 | 22534 |
| May 10, 2024 | Sell -- (Common Stock) | 10000 | 83.04 | 22205 |
| May 10, 2024 | M -- (Common Stock) | 10000 | 52.27 | 32205 |
| Feb 28, 2024 | Acquisition -- (Common Stock) | 7208 | 0 | 22205 |
| Feb 16, 2024 | F -- (Common Stock) | 593 | 74.65 | 14997 |
| Dec 30, 2023 | J -- (Common Stock) | 179 | 60.71 | 15590 |
| Aug 11, 2023 | F -- (Common Stock) | 897 | 68.73 | 15411 |
| Mar 25, 2023 | Sell -- (Common Stock) | 300 | 69.92 | 16308 |
| Feb 24, 2023 | Acquisition -- (Common Stock) | 5668 | 0 | 16608 |